LOS ANGELES, CA / ACCESSWIRE / February 18, 2020 / Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming February 28, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of Trulieve Cannabis Corp. ("Trulieve" or the "Company") (OTCQX:TCNNF) investors who purchased securities between September 25, 2018 and December 17, 2019, inclusive (the "Class Period").
If you are a shareholder who suffered a loss, click here to participate.
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com.
On December 17, 2019, Grizzly Research published a report alleging that most of the Company's cultivation space comes from "hoop houses that produce low quality output," that there were extensive ties between Trulieve and ongoing FBI investigations into corruption, that the Company's initial license approval "stinks of corruption," and that the Company engaged in undisclosed related party transactions.
On this news, Trulieve's share price fell $1.51, or more than 12%, to close at $10.40 per share on December 17, 2019, thereby injuring investors.
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Trulieve overstated its mark-up on its biological assets; (2) that Trulieve's reported gross profit was inflated; (3) that Trulieve engaged in an undisclosed related party real estate sale with Defendant Rivers' husband; and (4) that as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Follow us for updates on Twitter: twitter.com/GPM_LLP.
If you purchased or otherwise acquired Trulieve securities during the Class Period, you may move the Court no later than February 28, 2020 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com
SOURCE: Glancy Prongay & Murray LLP
View source version on accesswire.com:
https://www.accesswire.com/576861/Glancy-Prongay-Murray-Reminds-Investors-of-Looming-Deadline-in-the-Class-Action-Lawsuit-Against-Trulieve-Cannabis-Corp-TCNNF
